Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01
Strength
Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01
Pack Size
Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01
Form
Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01
Source
European Medicines Agency
Safety Profile
Contraindications
Side Effects
Scan this QR code to access this page quickly on your mobile device.